Latest Biosimilar Stories
LAKE FOREST, Ill., July 1, 2014 /PRNewswire/ -- Hospira, Inc.
ReportsnReports.com offers Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand
DALLAS, June 27, 2014 /PRNewswire/ -- According to the new market research report, "Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting,
Coherus Advances Development as Part of Collaboration with Daiichi Sankyo and Baxter REDWOOD CITY, Calif., June 23, 2014 /PRNewswire/ --
Industry experts Kevin Nelson and Dr. Patrick Gallagher from Duane Morris LLP will use examples from leading companies that are currently attempting to demonstrate biosimilarity.
Protecting consumers requires the ability to track products. Washington, DC (PRWEB) June 19, 2014 “The promise of personalized medicine will only be
HSINCHU, Taiwan, June 19, 2014 /PRNewswire/ -- JHL Biotech, Inc., an emerging biopharmaceutical company, today announced
DUBLIN, June 19, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the District of Delaware has found certain claims of United States Patent
Change in regulatory frameworks and standards are essential to expedite approval and release of innovative products LONDON, June 18, 2014 /PRNewswire/ -- Regenerative medicine has
GIA announces the release of a comprehensive global report on Human Growth Hormone Drugs markets.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.